A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...

The following is a summary of “Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy,” published in the ...

BioCity Biopharma’s selective endothelin receptor type A (ETA) antagonist has reduced excess proteins in the urine of ...

The following is a summary of “Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy,” published in the February 2025 issue of BMC ...

A new study identifies GPR107 as a key protein protecting against diabetic nephropathy (DN), a major cause of kidney failure.

A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway ...

This study is led by Dr. Haisheng Zhou (Department of Biochemistry and Molecular Biology, Anhui Medical University, China) and Dr. Guoling Zhou (Center for Computational Integrative Biology, ...

Colorado couple Ashley and Jimmy Cleverly were living a picture-perfect life, until a diagnosis left Jimmy in need of a ...

She was diagnosed with a genetic kidney disease called reflux nephropathy which later progressed to kidney failure. "That was ...

IgA nephropathy is an autoimmune disease of the kidneys. It’s associated with several health conditions and is a significant contributor to chronic kidney disease and kidney failure. In the ...

Groundbreaking research exposes how diabetes damages kidneys, offering hope through early detection and innovative prevention ...

Given the rise in such cases in India, THE WEEK spoke to four patients to discuss the impact chronic kidney disease has had ...